Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Silicon Motion Technology Corp. (ADR) (SIMO)’s Stock Destined for Greatness?

Page 1 of 2

Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Silicon Motion Technology Corp. (ADR) (NASDAQ:SIMO) fit the bill? Let’s take a look at what its recent results tell us about its potential for future gains.

What we’re looking for
The graphs you’re about to see tell Silicon Motion’s story, and we’ll be grading the quality of that story in several ways:

Growth: Are profits, margins, and free cash flow all increasing?
Valuation: Is share price growing in line with earnings per share?
Opportunities: Is return on equity increasing while debt to equity declines?
Dividends: Are dividends consistently growing in a sustainable way?

What the numbers tell you
Now, let’s take a look at Silicon Motion Technology Corp. (ADR) (NASDAQ:SIMO)’s key statistics:

SIMO Total Return Price data by YCharts.

Criteria 3-Year* Change Grade
Revenue growth > 30% 195.1% Pass
Improving profit margin 200.2% Pass
Free cash flow growth  > Net income growth 564.3% vs. 153.7% Pass
Improving EPS 233.4% Pass
Stock growth (+ 15%) < EPS growth 156.2% vs. 233.4% Pass

Sources: YCharts and Morningstar. *Period begins at end of Q1 2010. Free cash flow calculated from year-end 2010 to year-end 2012.

SIMO Return on Equity data by YCharts.

Criteria 3-Year* Change Grade
Improving return on equity 137.1% Pass
Declining debt to equity No debt Pass
Dividend growth > 25% Established in 2013 Pass
Free cash flow payout ratio < 50% Not available N/A

Source: YCharts. *Period begins at end of Q1 2010.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!